(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Entrada Therapeutics, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, April 25th, 2025 | 2024 | Nathan J. Dowden President and Chief Operating Officer | 480,000 | 0 | 1,278,263 | 216,010 | 13,800 | 2,460,688 |
| Friday, April 25th, 2025 | 2023 | Natarajan Sethuraman Ph. D. President of Research and Development | 456,501 | 0 | 392,772 | 224,598 | 13,200 | 1,485,455 |
| Friday, April 25th, 2025 | 2024 | Natarajan Sethuraman Ph. D. President of Research and Development | 493,232 | 0 | 605,493 | 221,980 | 11,980 | 1,962,700 |
| Friday, April 25th, 2025 | 2023 | Dipal Doshi Chief Executive Officer | 585,000 | 0 | 1,373,319 | 370,013 | 13,200 | 3,735,466 |
| Friday, April 25th, 2025 | 2024 | Dipal Doshi Chief Executive Officer | 610,000 | 0 | 1,437,531 | 335,510 | 13,800 | 3,891,503 |
| Friday, April 25th, 2025 | 2023 | Nathan J. Dowden President and Chief Operating Officer | 456,501 | 0 | 392,772 | 224,598 | 13,200 | 1,485,455 |
| Monday, April 29th, 2024 | 2023 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 456,501 | 0 | 392,772 | 224,598 | 13,200 | 1,485,455 |
| Monday, April 29th, 2024 | 2022 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 440,000 | 0 | 203,529 | 202,400 | 12,200 | 1,618,915 |
| Monday, April 29th, 2024 | 2022 | Nathan J. Dowden President and Chief Operating Officer | 440,000 | 0 | 186,916 | 202,400 | 12,200 | 1,540,389 |
| Monday, April 29th, 2024 | 2023 | Dipal Doshi Chief Executive Officer | 585,000 | 0 | 1,373,319 | 370,013 | 13,200 | 3,735,466 |
| Monday, April 29th, 2024 | 2022 | Dipal Doshi Chief Executive Officer | 565,000 | 0 | 546,618 | 324,875 | 12,200 | 3,491,063 |
| Monday, April 29th, 2024 | 2023 | Nathan J. Dowden President and Chief Operating Officer | 456,501 | 0 | 392,772 | 224,598 | 13,200 | 1,485,455 |
| Tuesday, April 25th, 2023 | 2021 | Nathan J. Dowden Chief Operating Officer | 378,532 | 50,000 | 0 | 176,920 | 0 | 2,312,017 |
| Tuesday, April 25th, 2023 | 2022 | Dipal Doshi President and Chief Executive Officer | 565,000 | 0 | 546,618 | 324,875 | 12,200 | 3,491,063 |
| Tuesday, April 25th, 2023 | 2021 | Dipal Doshi President and Chief Executive Officer | 425,057 | 117,500 | 0 | 233,050 | 12,500 | 5,530,399 |
| Tuesday, April 25th, 2023 | 2022 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 440,000 | 0 | 203,529 | 202,400 | 12,200 | 1,618,915 |
| Tuesday, April 25th, 2023 | 2021 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 382,939 | 60,000 | 0 | 178,930 | 0 | 4,306,614 |
| Tuesday, April 25th, 2023 | 2022 | Nathan J. Dowden Chief Operating Officer | 440,000 | 0 | 186,916 | 202,400 | 12,200 | 1,540,389 |
| Tuesday, April 19th, 2022 | 2021 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 382,939 | 60,000 | 0 | 178,930 | 0 | 4,306,614 |
| Tuesday, April 19th, 2022 | 2020 | Dipal Doshi President and Chief Executive Officer | 385,000 | 0 | 0 | 134,750 | 75,000 | 905,503 |
| Tuesday, April 19th, 2022 | 2021 | Dipal Doshi President and Chief Executive Officer | 425,057 | 117,500 | 0 | 233,050 | 12,500 | 5,530,399 |
| Tuesday, April 19th, 2022 | 2020 | Nathan Dowden Chief Operating Officer | 354,488 | 0 | 0 | 124,373 | 0 | 561,497 |
| Tuesday, April 19th, 2022 | 2021 | Nathan Dowden Chief Operating Officer | 378,532 | 50,000 | 0 | 176,920 | 0 | 2,312,017 |
| Tuesday, April 19th, 2022 | 2020 | Natarajan Sethuraman Ph. D. Chief Scientific Officer | 359,625 | 0 | 0 | 126,175 | 0 | 579,765 |
